Metabolic Flexibility Is a Determinant of Breast Cancer Heterogeneity and Progression

Metabolic Flexibility Is a Determinant of Breast Cancer Heterogeneity and Progression

Breast cancer progression is characterized by changes in cellular metabolism that contribute to enhanced tumour growth and adaptation to microenvironmental stresses. Metabolic changes within breast tumours are still poorly understood and are not as yet exploited for therapeutic intervention, in part...

Full description

Bibliographic Details
Main Authors:	Marina Fukano, Morag Park, Geneviève Deblois
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Series:	Cancers
Subjects:	breast cancer metabolic heterogeneity metabolic flexibility metabolic plasticity adaptive capacity epigenetic reprogramming
Online Access:	https://www.mdpi.com/2072-6694/13/18/4699

Similar Items

Breast Cancer Cell Subtypes Display Different Metabolic Phenotypes That Correlate with Their Clinical Classification
by: Consuelo Ripoll, et al.
Published: (2021-12-01)

Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer
by: Hang Chee Erin Shum, et al.
Published: (2023-01-01)

Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets
by: Xuewei Zheng, et al.
Published: (2022-12-01)

Mapping phenotypic heterogeneity in melanoma onto the epithelial-hybrid-mesenchymal axis
by: Maalavika Pillai, et al.
Published: (2022-08-01)

Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib<sup>+</sup>
by: Nicla Lorito, et al.
Published: (2020-03-01)

Flexibility and Adaptation of Cancer Cells in a Heterogenous Metabolic Microenvironment
by: Gabriele Grasmann, et al.
Published: (2021-02-01)

Editorial: Metabolic reprogramming in breast cancer
by: Cristian Scatena, et al.
Published: (2022-11-01)

A Review of Metabolic Targets of Anticancer Nutrients and Nutraceuticals in Pre-Clinical Models of Triple-Negative Breast Cancer
by: Alleigh Wiggs, et al.
Published: (2022-05-01)

Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
by: Tongxin Ge, et al.
Published: (2022-11-01)

Tumor Metabolic Reprogramming by Adipokines as a Critical Driver of Obesity-Associated Cancer Progression
by: Duc-Vinh Pham, et al.
Published: (2021-02-01)

Editorial: Metabolic Abnormalities and Breast Cancer: Challenges From Bench to Bedside
by: Zheng Wang, et al.
Published: (2022-04-01)

Mitochondria: the gatekeepers between metabolism and immunity
by: Giovanna Trinchese, et al.
Published: (2024-02-01)

Interplay between metabolic reprogramming and post-translational modifications: from glycolysis to lactylation
by: Hengwei Wu, et al.
Published: (2023-06-01)

Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
by: Enyong Dai, et al.
Published: (2021-12-01)

Metabolic Adaptation-Mediated Cancer Survival and Progression in Oxidative Stress
by: Yongquan Tang, et al.
Published: (2022-07-01)

Developmental Impacts of Epigenetics and Metabolism in COVID-19
by: Noopur Naik, et al.
Published: (2024-02-01)

Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy
by: Styliani Papadaki, et al.
Published: (2022-11-01)

The Development of Single-Cell Metabolism and Its Role in Studying Cancer Emergent Properties
by: Dingju Wei, et al.
Published: (2022-01-01)

Relationship between metabolic reprogramming and drug resistance in breast cancer
by: Linlin Lv, et al.
Published: (2022-08-01)

Myc derived circRNA promotes triple-negative breast cancer progression via reprogramming fatty acid metabolism
by: Shengting Wang, et al.
Published: (2023-05-01)

Regulation of Glucose, Fatty Acid and Amino Acid Metabolism by Ubiquitination and SUMOylation for Cancer Progression
by: Shunqin Zhu, et al.
Published: (2022-03-01)

NF1 deficiency drives metabolic reprogramming in ER+ breast cancer
by: Rachel (Rae) J. House, et al.
Published: (2024-02-01)

Research progress of hyperthermia in tumor therapy by influencing metabolic reprogramming of tumor cells
by: Yuchuan Yang, et al.
Published: (2023-12-01)

Transient Changes of Metabolism at the Pronuclear Stage in Mice Influences Skeletal Muscle Phenotype in Adulthood
by: Christelle Bertrand-Gaday, et al.
Published: (2020-09-01)

Linking Metabolic Reprogramming, Plasticity and Tumor Progression
by: Oleg Shuvalov, et al.
Published: (2021-02-01)

Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities
by: Jiske F. Tiersma, et al.
Published: (2022-03-01)

The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind?
by: Sara Loponte, et al.
Published: (2019-10-01)

Increased Ammonium Toxicity in Response to Exogenous Glutamine in Metastatic Breast Cancer Cells
by: Violet A. Kiesel, et al.
Published: (2022-05-01)

In Situ Metabolic Characterisation of Breast Cancer and Its Potential Impact on Therapy
by: Gábor Petővári, et al.
Published: (2020-09-01)

KEY PLAYERS IN CHOLINE METABOLIC REPROGRAMMING IN TRIPLE NEGATIVE BREAST CANCER
by: Egidio Iorio, et al.
Published: (2016-09-01)

Metabolic Reprogramming, Questioning, and Implications for Cancer
by: Pierre Jacquet, et al.
Published: (2021-02-01)

Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs
by: Fereydoon Abedi-Gaballu, et al.
Published: (2022-09-01)

Phytochemicals Target Multiple Metabolic Pathways in Cancer
by: Oleg Shuvalov, et al.
Published: (2023-11-01)

Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation
by: Veronica Vella, et al.
Published: (2019-09-01)

The Role of Aberrant Metabolism in Cancer: Insights Into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer
by: Yina Yu, et al.
Published: (2020-06-01)

Research Progress of Lipid Metabolism Reprogramming in Prostate Cancer
by: ZENG Kai, et al.
Published: (2022-08-01)

Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer
by: Jing Chen, et al.
Published: (2020-02-01)

Lipid Metabolism Heterogeneity and Crosstalk with Mitochondria Functions Drive Breast Cancer Progression and Drug Resistance
by: Aurelien Azam, et al.
Published: (2022-12-01)

Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors
by: Adviti Naik, et al.
Published: (2020-11-01)

Metabolic switching of human myotubes is improved by n-3 fatty acids
by: N.P. Hessvik, et al.
Published: (2010-08-01)